Cardinal Health Acquires Integrated Oncology Network for $1.115B

Integrated Oncology Network Acquires California Cancer Associates for Research & Excellence

April 22, 2022

Healthcare Services

Integrated Oncology Network (ION), a portfolio company of Silver Oak Services Partners, has acquired California Cancer Associates for Research & Excellence (cCARE). cCARE operates six cancer centers with over 30 providers across the Fresno and San Diego markets; the acquisition expands ION's platform to 57 centers across 14 states and is intended to accelerate growth and expand comprehensive, community-based oncology services.

Integrated Oncology Network Acquires Urology Partners, LLC

May 2, 2024

Healthcare Services

Integrated Oncology Network, LLC (ION), a portfolio company of Silver Oak Services Partners, has acquired Urology Partners, LLC, a private-practice urology group serving the greater Cleveland area. The deal combines Urology Partners with ION’s existing partner SouthWest Urology (and longtime partner Northern Ohio Regional Cancer Center) to expand urologic and prostate cancer care capacity and services across Cleveland and Ohio.

Cardinal Health Acquires Specialty Networks from Linden Capital for $1.2B

January 31, 2024

Healthcare Services

Cardinal Health has entered into a definitive agreement to acquire Specialty Networks, a technology-enabled multi-specialty group purchasing and practice enhancement organization, from Linden Capital Partners for $1.2 billion in cash. The deal adds Specialty Networks' GPOs, PPS Analytics platform and life-sciences/research capabilities to Cardinal Health's Specialty business to accelerate capability expansion across urology, gastroenterology and rheumatology.

Novo Integrated Sciences / Novo Healthnet Acquire Acenzia Inc.

June 29, 2021

Pharmaceuticals

Novo Integrated Sciences, through its wholly owned subsidiary Novo Healthnet Limited, completed the acquisition of Acenzia Inc., a Windsor, Ontario-based nutraceutical manufacturer and diagnostics developer. The all-share transaction closed on June 24, 2021 and is valued at $14,884,039; Novo said the purchase will give it direct control of development, manufacturing and distribution of wellness products and personalized diagnostics.

Digital Transformation Opportunities Corp. Completes Business Combination with American Oncology Network

September 20, 2023

Healthcare Services

Digital Transformation Opportunities Corp. (DTOC) completed its business combination with American Oncology Network (AON), and the combined company was renamed American Oncology Network, Inc., with common stock expected to trade on Nasdaq under the ticker AONC. The transaction includes a strategic investment from AEA Growth to provide capital to scale AON’s network, expand ancillary services (specialty pharmacy, lab/pathology, radiation, imaging) and add new providers and service offerings.

Novartis Acquires Mariana Oncology

May 2, 2024

Biotechnology

Novartis will acquire Mariana Oncology for $1 billion upfront and up to $750 million in milestone payments, bringing Mariana's peptide-based radiopharmaceutical pipeline and manufacturing capabilities into Novartis. The deal adds radioligand therapeutic discovery, isotope supply chain and manufacturing know-how to Novartis to accelerate development and commercialization of targeted cancer therapies.